Ripple Therapeutics, a clinical-stage company focused on polymer-free sustained-release drug delivery systems, has entered into a licensing agreement with Bausch Health to advance ocular delivery platforms. The deal aims to leverage Ripple’s polymer-free technology to enhance the sustained release of therapeutics in the eye, potentially improving treatment adherence and patient outcomes.
Key points:
- Partnership scope: Bausch Health licenses Ripple’s polymer-free sustained-release technology for ocular applications.
- Strategic aim: Improve duration of drug exposure in ocular tissues while reducing dosing frequency.
- Implications for patients: Potentially fewer injections or administrations could be required, enhancing convenience and adherence.
- Market potential: Could expand options for treating chronic eye diseases with improved delivery profiles.
Quotes:
- Ripple spokesperson: “The collaboration with Bausch Health marks a significant step in bringing polymer-free delivery to the eye, with potential benefits for patients and clinicians.”
- Bausch Health representative: “This licensing agreement aligns with our commitment to innovative ocular therapies that can improve patient outcomes.”
Context: Ripple Therapeutics develops drug delivery systems that avoid polymer matrices, instead relying on alternative mechanisms to sustain drug release. The collaboration with Bausch Health suggests a path toward bringing these technologies into commercial ocular therapies, potentially influencing how eye diseases are treated in the future.
Limitations: The article notes that more details about the exact terms, timelines, and specific drug candidates remain undisclosed, and further updates are expected as development progresses.
Author's summary: Ripple and Bausch’s licensing pact aims to bring polymer-free, sustained-release ocular delivery closer to market, potentially reducing treatment frequency and improving adherence. (120–200 characters)
More News
- Top Stories: iOS 26.2 Coming Soon
- Packers Vs. Lions - 3 Plays That Make You Go Hmmm
- Release candidates of iOS 26.2, macOS 26.2 now available
- 15 New Things Your iPhone Can Do in iOS 26.2
- Who Is Controversial AI Star, Tilly Norwood's Creator?
- 33 "Stranger Things" Season 5, Vol. 1 Easter Eggs And Very Clever Details
- Tilly Norwood Studio Expanding “Tilly-verse” With New Roles Advertised
- “Pretend I’m a fishing boat and fire away”: Jost plays Hegseth in “SNL” cold open
- Black Ops 7 Zombies Astra Malorum Main Easter Egg Guide
- Discover New Zootopia 2 Easter Eggs at Shanghai Disney Resort